comparing cardiovascular and kidney outcomes with tirzepatide vs. glp-1 agonists Comparative efficacy of glucagon-like peptide-1 receptor on in patients type 2 diabetes: a systematic review and network meta-analysis | Cardiovascular Diabetology comparing cardiovascular and kidney outcomes

PubMed laboratory research record [PMID: 34356860] PubMed record related to this compound for laboratory literature review

Efficacy differs measurably in trials, with semaglutide showing up to about 15% average body weight reduction over extended study periods versus roughly 9% average weight loss for liraglutide at 12 months

Similarly, luxury fitness brand Equinox has created a personal training program designed for its members who take GLP-1s, offering fitness and nutrition advice to help them form long-term, healthy habits around weight loss and fitness

The median shipment size was 51g, which might seem small, but 1g is equivalent to 4,000 starting doses of semaglutide